Trial Profile
Evaluation of Efficacy and Safety of Nicotine-Qbeta (NicQb) Vaccine Versus Placebo in Healthy Smokers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2014
Price :
$35
*
At a glance
- Drugs NIC 002 (Primary)
- Indications Drug dependence
- Focus Adverse reactions; Therapeutic Use
- Sponsors Cytos Biotechnology
- 07 Nov 2014 New trial record